Nice write up on MXC
See, a crucial commercial marijuana license announcement, which the Courier Mail says is ‘likely to be approved within weeks’ has the power to make gains already racked up by Australia’s early ‘pot plays’ like MGC Pharmaceuticals, Botanix and Medlab
- MGC Pharmaceuticals [ASX:MXC] sells a range of cannabinoid derived anti-ageing skincare products in California, Canada and the European Union. An early punt on MGC could have helped you to a ‘high-bagger’ 1,233% gain in only 26 months.
Source: Yahoo Finance
Eye-watering gains, yes?
Remember though, the above stocks are fresh examples inside a —
ahem — ‘green’ healthcare sub-sector.
Which means they’re a lot riskier than your everyday blue-chip healthcare stocks like CSL, Resmed or Cochlear.
And you should only ever use money on higher risk small-cap stocks that won’t ‘break the bank’.
But where there’s higher risk, you’ve also got a potential shot at creating immense fortunes.
Take another look at the last Aussie marijuana stock I showed you, MGC Pharmaceuticals. Since 2015, shares are up 1,233%.
A small $500 punt turned into $6,165 in just 26 months. Enough to walk out the front doors of Harvey Norman with a brand-spanking-new, 75 inch Sony Bravia HD TV under your arm.
If you’d had a little more money to risk — say $5,000 — you’d have $61,650 sitting in your brokerage account right now. The kind of money that lets you deck out a whole private cinema room in your home…or even put a deposit down on a new house!
Again, exciting as those gains sound…I believe it’s nothing more than a dress rehearsal for what comes
next.
See, a crucial commercial marijuana license announcement, which the Courier Mail says is ‘likely to be approved within weeks’ has the power to make gains already racked up by Australia’s early ‘pot plays’ like MGC Pharmaceuticals, Botanix and Medlab look tiny.
Few mainstream analysts understand the magnitude of this announcement…
Fewer still know what it means for the fortunes of one specific pot stock at the centre of Australia’s fledgling marijuana industry.
In short, it could see this tiny marijuana stock grab a big slice of an international medicinal marijuana market that Bank of America Merrill Lynch estimates could be worth as much as $35 billion in the next three years.
That’s why you need to look at this now. By the end of this month, your chance to PROFIT from this could be gone.
Right now, this company’s market cap is just $52 million. While that sounds big, in market terms that’s tiny.
But picture this…
Just 1% of that $35 billion marijuana market ($350,000,000!) would instantly re-rate this firm’s market value — and its shares — SEVENFOLD.
And that’s only the start.
Motley Fool reports legal marijuana could soon rival the
‘$200 billion alcohol industry’.
Bottom line: this is your shot to jump on an emerging market move you won’t see again in your lifetime.
Position yourself in the Aussie marijuana stock at the centre of this boom now and you could make a certified fortune. Here’s how…
